CB-839
Showing 26 - 50 of 245
CB-Long-Term Safety Study (CB-LTSS)
Enrolling by invitation
- Lymphoma, Non-Hodgkin
- +7 more
- Allogeneic CAR-T therapy
-
Irvine, California
- +3 more
Nov 18, 2022
Prader-Willi Syndrome Trial in Bronx (CBDV Compound, Placebo)
Recruiting
- Prader-Willi Syndrome
- CBDV Compound
- Placebo
-
Bronx, New YorkMontefiore Medical Center, Albert Einstein College of Medicine
Dec 1, 2021
PTSD, Intrusive Traumatic Memories Trial in Lausanne (A single-session behavioral intervention composed of a brief evocation of
Recruiting
- Posttraumatic Stress Disorder
- Intrusive Traumatic Memories
- A single-session behavioral intervention composed of a brief evocation of the childbirth memory followed by a Tetris gameplay
-
Lausanne, Vaud, SwitzerlandAntje Horsch
Jul 15, 2022
Stroke, Ischemic, Quadrantanopia, Hemianopsia, Homonymous Trial in Rochester (Virtual Reality Driving Task)
Not yet recruiting
- Stroke, Ischemic
- +10 more
- Virtual Reality Driving Task
-
Rochester, New YorkUniversity of Rochester
Sep 22, 2023
Dental Caries Trial in Araçatuba (Applications of self-etching adhesives and dental restorations)
Completed
- Dental Caries
- Applications of self-etching adhesives and dental restorations
-
Araçatuba, Sao Paulo, BrazilCristiane Duque
Jan 4, 2023
Clostridium Difficile Infection Trial (CB-183,315, Vancomycin, Placebo)
Sickle Cell Disease, Umbilical Cord Blood, Hematopoietic Cell Proliferation Trial in Palo Alto, San Francisco (ECT-001-CB
Withdrawn
- Sickle Cell Disease
- +2 more
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
Palo Alto, California
- +1 more
Jun 29, 2022
Bacterial Infections Trial in Bangkok (Colistin Sulfomethate)
Completed
- Bacterial Infections
- Colistin Sulfomethate
-
Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Nov 24, 2022
Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)
Recruiting
- Dry Age-related Macular Degeneration
- Intravitreal injection of CB-PRP
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023
System for the Anticipation of Challenging Behaviors
Completed
- Autism Spectrum Disorder
- Smart, non-invasive shirt - Physiological parameters
- +2 more
-
Ariel, IsraelAriel University
Dec 29, 2022
Hematopoietic and Lymphoid Cell Tumor, Steroid Refractory GVHD Trial in Houston (Cellular Therapy, Ruxolitinib)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Steroid Refractory Graft Versus Host Disease
- Cellular Therapy
- Ruxolitinib
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Recurrent Gliosarcoma, Recurrent Supratentorial Glioblastoma, Supratentorial Gliosarcoma Trial in Houston (Cord Blood-derived
Not yet recruiting
- Recurrent Gliosarcoma
- +2 more
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells
- Resection
-
Houston, TexasM D Anderson Cancer Center
May 24, 2022
Hematological Malignancy Trial in Houston (Fludarabine Phosphate, Cyclophosphamide, CAR.5/IL15-transduced CB-NK cells)
Not yet recruiting
- Hematological Malignancy
- Fludarabine Phosphate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Medial Tab Flap for Soft Tissue Defects of the Leg
Completed
- Leg Coverage Defects
- Medial tab-type fasciocutaneous flap
-
Barranquilla, Atlantico, ColombiaFundacion Campbell
May 17, 2023
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,
Recruiting
- Lymphoma, Non-Hodgkin
- +6 more
- CB-010
- +2 more
-
Scottsdale, Arizona
- +7 more
Aug 19, 2022
Trichotillomania, Skin-Picking Trial in Chicago (Dronabinol, Placebo)
Completed
- Trichotillomania
- Skin-Picking
- Dronabinol
- Placebo
-
Chicago, IllinoisUniversity of Chicago
May 11, 2022
Colon Cancer, Resected Stage Trial in Houston (Cetuximab, CB-NK-TGF-βR2-/NR3C1, Fludarabine phosphate)
Recruiting
- Colon Cancer
- Resected Stage
- Cetuximab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 23, 2022
Post Traumatic Stress Disorder, Childbirth Experience Trial in Lausanne (Head-mounted display)
Recruiting
- Post Traumatic Stress Disorder
- Childbirth Experience
- Head-mounted display
-
Lausanne, SwitzerlandProf. Antje Horsch
Jun 3, 2022
Leukemia, Lymphoblastic, Leukemia Trial in Houston (CB-103, Venetoclax)
Not yet recruiting
- Leukemia, Lymphoblastic
- Leukemia
-
Houston, TexasMD Anderson Cancer Center
Jul 19, 2022
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
- CB-103
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 14, 2023
Multiple Myeloma Trial in Montréal (ECT-001 (UM171) expanded cord blood)
Active, not recruiting
- Multiple Myeloma
- ECT-001 (UM171) expanded cord blood
-
Montréal, Quebec, CanadaCIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maiso
Mar 8, 2022
High Risk Hematological Malignancy, Cord Blood Transplant Trial in Seattle (ECT-001-CB (UM171-Expanded Cord Blood Transplant))
Recruiting
- High Risk Hematological Malignancy
- Cord Blood Transplant
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
Seattle, WashingtonFred Hutchinson / University of Washington Cancer Consortium
Jan 12, 2022
High Risk Myeloid Malignancies, Cord Blood Transplant Trial in New York (ECT-001-CB (UM171-Expanded Cord Blood Transplant))
Recruiting
- High Risk Myeloid Malignancies
- Cord Blood Transplant
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 12, 2022
Cataract Trial in Wenzhou (SN6AD1, SBL-3, LS-313 MF30)
Recruiting
- Cataract
- SN6AD1
- +5 more
-
Wenzhou, Zhejiang, ChinaThe Eye Hispital of Wenzhou Medical University
Oct 4, 2021